Pulmonary surfactant in cystic fibrosis

European Respiratory Journal

Volumn 10, Issue 9, 1997, Pages 1983-1988

  Griese, M ^a   Birrer, P ^b   Demirsoy, A ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Phospholipids; Surface tension; Surfactant protein A; Surfactant protein B

Indexed keywords

LUNG SURFACTANT; PHOSPHOLIPID; PROTEIN A;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; HUMAN; LUNG LAVAGE; MALE; PRIORITY JOURNAL; SURFACE TENSION;

ADOLESCENT; ADULT; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; HUMANS; MIDDLE AGED; PHOSPHOLIPIDS; PROTEINS; PROTEOLIPIDS; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; PULMONARY SURFACTANTS; SURFACE TENSION;

EID: 0030930737     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.97.10091983     Document Type: Article

References (26)

1. Davis PB. Pathophysiology of the lung disease in cystic fibrosis. In: Davis PB, ed. Cystic Fibrosis. New York, Marcel Dekker, Inc, 1993; pp. 193-218.
2. Macklem PT, Proctor DF, Hogg JC. The stability of peripheral airways. Respir Physiol 1970; 8: 191-203.
3. Liu M, Wang L, Li E, Enhorning G. Pulmonary surfactant will secure free airflow through a narrow tube. J Appl Physiol 1991; 71: 742-748.
4. Enhorning C, Duffy LC, Welliver RC. Pulmonary surfactant maintains patency of conducting airways in the rat. Am J Respir Crit Care Med 1995; 151: 554-556.
5. Enhorning G, Holm BA. Disruption of pulmonary surfactant's ability to maintain openness of a narrow tube. J Appl Physiol 1993; 74: 2922-2927.
6. Seeger W, Grube C, Günther A, Schmidt R. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur Respir J 1993; 6: 971-977.
7. Sahu S, Lynn WS. Lipid composition of airways secretion from patients with asthma and patients with cystic fibrosis. Am Rev Respir Dis 1977; 115: 233-239.
8. Sharma A, Meyer K, Zimmerman J. Surfactant protein A depletion in patients with cystic fibrosis. Am J Respir Crit Care Med 1994; 149: A670.
9. Mander A, Hockey M, Wang JY, Warner JO, Postle AD. Pulmonary surfactant composition of bronchoalveolar lavage (BAL) fluid from children with cystic fibrosis. Eur Respir J 1996; 8: Abstract 1160.
10. Gilljam H, Andersson O, Ellin A, Robertson B, Strandvik B. Composition and surface properties of the bronchial lipids in adult patients with cystic fibrosis. Clin Chim Acta 1988; 176: 29-38.
11. Demirsoy A, Griese M, Birrer P, Schams A, Schürmann A, Reinhardt D. Bronchoalveoläres Surfactant bei cystischer Fibrose (CF). Monatsschr Kinderheilkd 1996; 144: 341, P3.
12. Kraemer R, Ruedberg A, Klaey M, Rossi E. Relationship between clinical conditions, radiographic findings and pulmonary functions in patients with cystic fibrosis. Helv Pediatr Acta 1979; 34: 417-428.
13. Gross NJ, Schultz RM. Serine protease requirement for the extracellular metabolism of pulmonary surfactant. Biochim Biophys Acta 1990; 1044: 222-230.
14. Veldhuizen RAW, Inchley K, Hearn SA, Lewis JF, Possmayer JF. Degradation of surfactant-associated protein B (SP-B) during in vitro conversion of large to small surfactant aggregates. Biochem J 1993; 295: 141-147.
15. Griese M, Dietrich P, Potz C, Westerburg B, Bals R, Reinhardt D. Surfactant subtractions during nosocomial infection in ventilated preterm human neonates. Am J Respir Crit Care Med 1996; 153: 398-403.
16. Krämer HJ, Schmidt R, Günther A, Becker G, Suzuki Y, Seeger W. ELISA technique for quantification of surfactant protein B (SP-B) in bronchoalveolar lavage fluid. Am J Respir Crit Care Med 1995; 152: 1540-1544.
17. Griese M, Westerburg B, Potz C, Dietrich P. Respiratory support, surface activity and protein content during noscomial infection in preterm neonates. Biol Neonate 1996; 70: 271-279.
18. Ikegami M, Jacobs H, Jobe A. Surfactant function in respiratory distress syndrome. J Pediatr 1983; 102:443-447.
19. Baughman RP, Stein E, MacGee J, Rashkin M, Sahebjami H. Changes in fatty acids in phospholipids of bronchoalveolar fluid in bacterial pneumonia and in adult respiratory distress syndrome. Clin Chem 1984; 30: 521-523.
20. Sachse K. Changes in the relative concentrations of surfactant phospholipids in young pigs with experimental pneumonia. J Vet Med 1989; 36: 385-390.
21. Günther A, Siebert C, Schmidt R, et al. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med 1996; 153: 176-184.
22. Brogden KA. Changes in pulmonary surfactant during bacterial pneumonia. Antonie van Leeuwenhoek 1991; 59: 215-223.
23. Baughman RP, Sternberg RI, Hull W, Buchsbaum JA, Whitsett J. Decreased surfactant protein A in patient with bacterial pneumonia.AmRevRespirDis 1993; 147:653-657.
24. de Bentzmann SG, Pierrot D, Fuchey C, Zahm JM, Morancais JL, Puchelle E. Distearoyl phosphatidylglycerol liposomes improve surface and transport properties of CF mucus. Eur Respir J 1993; 6: 1156-1161.
25. de Sanctis GT, Tomkiewicz RP, Rubin BK, Schürch S, King M. Exogenous surfactant enhances mucociliary clearance in the anaesthetized dog. Eur Respir J 1994; 7: 1616-1621.
26. van Golde LMG. Potential role of surfactant proteins A and D in innate lung defense against pathogens. Biol Neonate 1995; 67: 2-17.